関西医科大学附属病院新薬開発科 | Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

Study Details | NCT07227298 | Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers | ClinicalTrials.gov

NCT番号: NCT07227298

他の登録番号

治験責任医師: 清水俊雄

製薬企業（治験依頼者）: Pfizer

参加条件

医師・医学生お問い合わせ

FAQ

Clinical trials for patients and medical professionals

患者・医療関係者向け治験関するFAQ

詳しく見る

Towards “Five-Stars” Phase 1 Center of Excellence

Department of New Experimental Therapeutics
Early-Phase 1 Drug Development Service

Contact

お問い合わせ